These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 3895468)
1. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo. Chalkley LJ; Trinci AP; Pope AM Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468 [TBL] [Abstract][Full Text] [Related]
2. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412 [TBL] [Abstract][Full Text] [Related]
3. Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans. Han Y Phytomedicine; 2007 Nov; 14(11):733-8. PubMed ID: 17913484 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis. Han Y Int Immunopharmacol; 2010 Dec; 10(12):1526-31. PubMed ID: 20840836 [TBL] [Abstract][Full Text] [Related]
5. Uptake and killing of Candida by human peritoneal macrophages and amphotericin B. Linde HJ; Stille W; Shah PM Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):79-84. PubMed ID: 8007745 [TBL] [Abstract][Full Text] [Related]
6. Effect of amphotericin B alone or in combination with rifampicin on phagocytosis of Candida species by human polymorphonuclear leukocytes. Schaumann RF; Shah PM Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):753-8. PubMed ID: 1297891 [TBL] [Abstract][Full Text] [Related]
7. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione. Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730 [TBL] [Abstract][Full Text] [Related]
8. Tolerance to amphotericin B in clinical isolates of Candida tropicalis. Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603 [TBL] [Abstract][Full Text] [Related]
9. Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes). Kretschmar M; Amselem S; Zawoznik E; Mosbach K; Dietz A; Hof H; Nichterlein T Mycoses; 2001; 44(7-8):281-6. PubMed ID: 11714063 [TBL] [Abstract][Full Text] [Related]
10. Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophages. Allwinn R; Schaumann R; Shah PM Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):163-7. PubMed ID: 8531506 [TBL] [Abstract][Full Text] [Related]
11. Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo. Cacciapuoti A; Gurnani M; Halpern J; Norris C; Patel R; Loebenberg D Antimicrob Agents Chemother; 2005 Feb; 49(2):638-42. PubMed ID: 15673745 [TBL] [Abstract][Full Text] [Related]
12. [Effect of amphotericin B on the energy metabolism of tissue forms of Candida albicans]. Arabiĭskiĭ RA; Mikhaĭlova NG Antibiotiki; 1979 Oct; 24(10):758-61. PubMed ID: 386938 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies on synergistic antifungal activity. Shadomy S Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191 [No Abstract] [Full Text] [Related]
15. High purity amphotericin B. Cleary JD; Chapman SW; Swiatlo E; Kramer R J Antimicrob Chemother; 2007 Dec; 60(6):1331-40. PubMed ID: 17921178 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. Kucukates E; Erturan Z; Susever S; Yegenoglu Y APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609 [TBL] [Abstract][Full Text] [Related]
17. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole. Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925 [TBL] [Abstract][Full Text] [Related]
18. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Raad II; Hachem RY; Hanna HA; Fang X; Jiang Y; Dvorak T; Sherertz RJ; Kontoyiannis DP Int J Antimicrob Agents; 2008 Dec; 32(6):515-8. PubMed ID: 18783924 [TBL] [Abstract][Full Text] [Related]
19. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis. Kretschmar M; Nichterlein T; Hannak D; Hof H Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344 [TBL] [Abstract][Full Text] [Related]
20. Reduction of amphotericin resistance in stationary phase cultures of Candida albicans by treatment with enzymes. Gale EF; Ingram J; Kerridge D; Notario V; Wayman F J Gen Microbiol; 1980 Apr; 117(2):383-91. PubMed ID: 6999116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]